, Tracking Stock Market Picks
Enter Symbol:
Mast Therapeutics Inc. (MSTX) [hlAlert]

down 30.37 %

Adventrx Pharmaceuticals, Inc. (ANX) rated Buy

Posted on: Tuesday,  Oct 2, 2007  9:25 AM ET by Dawson James

Dawson James rated Buy Mast Therapeutics Inc. (AMEX: MSTX) on 10/02/2007. Previously Dawson James rated Sell Mast Therapeutics Inc. (AMEX: MSTX) on
10/01/2007., when the stock price was $13.75. Since then, Mast Therapeutics Inc. has gained 43.64% as of 10/02/2007's recent price of $19.75.
If you would have followed the previous Dawson James's recommendation on MSTX, you would have lost 30.37% of your investment in 1 days.

ADVENTRX Pharmaceuticals, Inc. (ADVENTRX) is a development-stage biopharmaceutical company. The Company?s business is focused on in-licensing, developing and commercializing product candidates for the treatment of cancer. Its lead product candidates, ANX-530 and ANX-514, are emulsion formulations of marketed chemotherapy drugs. ADVENTRX is focused primarily on evaluating strategic options, including the sale or exclusive license of one or more of its product candidate programs, a strategic business merger and other similar transactions. In October 2008, ADVENTRX announced that it had discontinued active work on all product candidates other than ANX-530 and ANX-514. Its wholly owned subsidiaries include SD Pharmaceuticals, Inc. (SDP) and ADVENTRX (Europe) Ltd.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/2/2007 9:25 AM Buy
19.75 30.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/1/2007 9:25 AM Sell
13.75 31.25

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy